<DOC>
	<DOCNO>NCT00811343</DOCNO>
	<brief_summary>Tuberculosis current infection anti TNF therapy . After infectious contact , patient develop tuberculosis infect without symptom , Latent Tuberculosis Infection ( LTBI ) wich reactivate later . In order prevent tuberculosis reactivation , LTBI diagnosis screen preconised patient need anti TNF therapy . This diagnosis make till tuberculin skin test ( TST ) test specific TB . New blood test ( QFTB-G T-SPOT.TB ) specific MTB infection available . The primary endpoint study evaluation theoric therapeutic impact use new test diagnosis LTBI patient anti TBF therapy</brief_summary>
	<brief_title>Impact New Immunological Diagnosis Tests Latent Tuberculosis Before Anti TNF Therapy</brief_title>
	<detailed_description>Detailed description : Principal outcome : Therapeutic impact use new test diagnosis LTBI patient anti TBF therapy Secondary outcome : - medico-economic impact replacement TST QFTB-G T-SPOT.TB test LTBI screen patient anti TNF therapy . - concordance QFTB-G T-SPOT.TB test result TST - Concordance QFTB-G T-SPOT.TB test evaluation indetermined test . - concordance QFTB-G T-SPOT.TB test result patient disease . - concordance QFTB-G T-SPOT.TB test result TST patient LTBI determinated clinical radiological observation - Impact geographical , disease treatment patient LTBI determinated clinical radiological observation - Identify original characteristic maximal impact therapeutic QFTB-G T-SPOT.TB test Analysed criterion : - therapeutic impact - Patients percentage different therapeutic outcome base usual recommendation medico-economic - Medico-economic impact : impact test early late cost - efficacy Statistic : - Primary criterion : Percentage patient therapeutic would change QFTB-G T-SPOT.TB test result compare usual diagnosis strategy . - Secondary criterion : Concordance QFTB-G T-SPOT.TB test TST Concordance QFTB-G T-SPOT.TB test . 400 patient Timing : inclusion : 1 year</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<criteria>18 year old Patient rheumatoid arthritis Ankylosing spondylitis Crohn 's disease Patient without Anti TNF treatment need one infliximab , adalimumab etanercept Consent sign Patient social right Patient examine Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>anti TNF Therapy</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>Tuberculin test</keyword>
	<keyword>QFTB-G</keyword>
	<keyword>T-SPOT.TB</keyword>
	<keyword>Need anti TNF Therapy</keyword>
</DOC>